Royal Fund Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100
Closed -$16.4K 351
2025
Q1
$16.4K Buy
+100
New +$15.6K ﹤0.01% 328
2024
Q4
Sell
-700
Closed -$113K 323
2024
Q3
$113K Buy
+700
New +$112K 0.01% 322
2024
Q2
Sell
-800
Closed -$127K 312
2024
Q1
$127K Sell
800
-100
-11% -$15.9K 0.01% 308
2023
Q4
$141K Buy
+900
New +$138K 0.02% 281
2023
Q3
Sell
-700
Closed -$116K 284
2023
Q2
$116K Buy
+700
New +$113K 0.01% 260
2023
Q1
Sell
-200
Closed -$35.3K 275
2022
Q4
$35.3K Buy
+200
New +$34.5K 0.01% 261

Other funds holding JNJ

Royal Fund Management's JNJ Position: Q2 2026 in Review

Royal Fund Management increased its Johnson & Johnson (JNJ) stake by 1.5% in Q2 2026, buying an estimated $128K and bringing the position to 37,731 shares worth $9.58M. The position accounts for 0.8% of the portfolio, ranked #33.

Royal Fund Management first reported a position in JNJ in Q4 2016 and has held it in 39 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Royal Fund Management held 37,731 shares of Johnson & Johnson worth $9.58M as of Q2 2026.
  • Royal Fund Management bought 550 Johnson & Johnson shares in Q2 2026, an estimated $128K.
  • Johnson & Johnson made up 0.8% of Royal Fund Management's portfolio in Q2 2026, its #33 holding.
  • Royal Fund Management first reported a position in Johnson & Johnson in Q4 2016 and has held it in 39 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Royal Fund Management's 13F filing for Q2 2026, filed 20 Jul 2026.